Tal Zaks logo

Tal Zaks

Chairman and Interim Chief Executive Officer at Exsilio Therapeutics · Investor at OrbiMed

Investments
5
Lead Investments
2
Newton, Massachusetts, United States, US

Highlights

Focus Areas

Biotechnology
Health Care
Medical
Biopharma
Genetics

Firms Invested Under

Recent Investments

Curevo logo
Minervax logo
Convergent Therapeutics logo

Firm Investments